Advertisement

Neuroprotective Actions of Green Tea Polyphenol, (-)-Epigallocatechin-3-Gallate in Models of Parkinson’s Disease: Gene Targets

  • Silvia Mandel
  • Yona Levites
  • Orly Weinreb
  • Moussa B. H. Youdim
Part of the Advances in Behavioral Biology book series (ABBI, volume 53)

Abstract

Biochemical evidence points to central roles for oxidative stress (OS) and inflammation in neuronal death in both idiopathic and animal models of Parkinson’s disease (PD). Reports from our laboratory, as supported by others, point to the presence of ongoing OS and inflammatory processes occurring selectively in the substantia nigra pars compacta (SNPC) of parkinsonian brains and in animal models of PD.1–4 Therefore, drugs that exhibit free radical-scavenging and iron chelating properties, may serve as potential candidates for the treatment of PD.

Keywords

Neuronal Cell Culture Cell Cycle Pathway Parkinsonian Brain EGCG Concentration Nuclear Factor kappaB Activity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Youdim M.B.H., Ben-Shachar D. and Riederer P., 1993, The possible role of iron in theetiopathology of Parkinson’s disease. Mov. Disord. 8:1–12.PubMedCrossRefGoogle Scholar
  2. 2.
    Gerlach M., Ben-Shachar D., Riederer P. and Youdim M.B.H., 1994, Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:793–806.PubMedCrossRefGoogle Scholar
  3. 3.
    Jenner P. and Olanow C.W., 1996, Pathological evidence for oxidative stress in Parkinson’s disease and related degenerative disorders. in: Neurodegeneration and neuroprotection in Parkinson’s disease, C.W. Olanow, P. Jenner, M.B.H. Youdim, eds., Academic Press, London, pp. 24–45.Google Scholar
  4. 4.
    Grünblatt E., Mandel S., Maor G. and Youdim M.B.H., 2001, Gene expression analysis in MPTP model of Parkinson’s disease using cDNA microarray: effect of R-apomorphine. J. Neurochem. 78:1–12.PubMedCrossRefGoogle Scholar
  5. 5.
    Nanjo F., Goto K., Seto R., Suzuki M., Sakai M., Hara Y., 1996, Scavenging effects of teacatechins and their derivatives on l, l-diphenyl-2-picrylhydrazyl radical. Free Radie. Biol. Med. 21:895–902.CrossRefGoogle Scholar
  6. 6.
    Salah N., Miller N.J., Paganga G., Tijburg L., Bolwell G.P., Rice-Evans C., 1995, Polyphenols flavanols as scavengers of aqueous phase radicals and as chain-breaking antioxidants. Arch. Biochem. Biophy. 322:339–346.CrossRefGoogle Scholar
  7. 7.
    Guo Q., Zhao B., Li M., Shen S., Xin W., 1996, Studies on protective mechanisms of four components of green tea polyphenols against lipid peroxidation in synaptosomes. Biochim. Biophys. Acta 1304:210–222.PubMedCrossRefGoogle Scholar
  8. 8.
    Haqqi T.M., Anthony D.D., Gupta S., Ahmad N., Lee M.S., Kumar G.K., Mukhtar H., 1999, Prevention of collagen-induced arthritis in mice by apolyphenolic fraction from green tea. Proc. Nat .Acad. Sci. USA 96:4524–4529.PubMedCrossRefGoogle Scholar
  9. 9.
    Pan M.H., Lin-Shiau S.Y., Ho C.T., Lin J.H., Lin J.K., 2000, Suppression oflypopolysaccharide-induced nuclear factor kappaB activity by theaflavin-3, 3, -digallate from tea and otherpolyphenols through down- regulation of IkappaB kinase activity in macrophages. Biochem. Pharmacol. 59:357–367.PubMedCrossRefGoogle Scholar
  10. 10.
    Levites Y., Weinreb O., Maor G., Youdim M.B.H. and Mandel, S., 2001, Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-l , 2, 3, 6-tetrahydropyridine-induced dopaminergic neurodegeneration J. Neurochem. 78(5): 1073–1082PubMedCrossRefGoogle Scholar
  11. 11.
    Levites Y., Youdim M.B.H., Maor G. and Mandel, S., 2001a, Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappaB (NF-kB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol. In press.Google Scholar
  12. 12.
    Grünblatt E., Mandel S., Berkuzki T. and Youdim M.B.H., 1999, Apomorphine protects against MPTP-induced neurotoxicity in mice. Mov. Disord. 14:612–618.PubMedCrossRefGoogle Scholar
  13. 13.
    Halliwell B., 1996, Vitamin C: antioxidant or pro-oxidant in vivo? Free Radic. Res. 25:439–454.PubMedCrossRefGoogle Scholar
  14. 14.
    Gassen M., Gross A. and Youdim M.B.H., 1998, Apomorphineenantiomers protect pheochromocytoma (PC 12) cells from oxidative stress induced by hydrogen peroxide and 6-hydroxydopamineMov. Disord. 13:242–248.CrossRefGoogle Scholar
  15. 15.
    Yang E. and Korsmeyer S.J., 1996, Molecularthanatopsis: a discourse on the BCL2 family and cell death. Blood, 88:386–401.PubMedGoogle Scholar
  16. 16.
    Slikker W., Youdim M.B., Palmer G.C., Hall E., Williams C., Trembly B., 1999, The future of neuroprotection. Ann. NY Acad. Sci. 890:529–533.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Silvia Mandel
  • Yona Levites
  • Orly Weinreb
  • Moussa B. H. Youdim
    • 1
  1. 1.Department of Pharmacology, Technion- Faculty of MedicineEve Topf and USA National Parkinson Foundation Centers of Excellence for Neurodegenerative Diseases ResearchHaifaIsrael

Personalised recommendations